Problemi correnti
Quando eseguire la cistouretrografia nei lattanti alla prima infezione delle vie urinarie?
When should cystourethrography be performed in infants at their first urinary tract infection?
Federico Marchetti, Carlotta Farneti, Sara Pusceddu, Luca Casadio
UOC di Pediatria e Neonatologia, Ospedale di Ravenna, AUSL della Romagna
Aprile 2018 - pagg. 229 -233
Abstract
Urinary tract infection (UTI) is the most common bacterial infection in infants. It may be associated
with the concomitant presence of a kidney malfunctioning picture, in particular
vescicoureteral reflux (VUR). Voiding cystourethrography (VCUG) is the gold standard
method to diagnose VUR but it is an invasive procedure that is not free of risk. The indication
of micturating cystourethrography (MCU) in infant at the first episode of UTI does not
find in the literature the unique recommendations. VUR has usually a benign prognosis
and the attitude followed for its management is in most cases waiting, without any specific
intervention. In fact both antibiotic prophylaxis and surgery do not substantially improve
the prognosis of VUR. The likelihood of being faced with a high grade of VUR (≥ III grade)
in infants at the first UTI is very high (about 50% of cases) in the presence of two risk conditions:
an infection caused by non-E. Coli and a concomitant abnormality in renal ultrasound.
In cases of E. coli infection and with normal renal ultrasound (which are the majority)
the likelihood of finding a high grade underlying VUR is very low (1% of cases).
Parole chiave
Suggerite dall'AI
Classificazione MeSH
Contenuto riservato
Per leggere l'articolo completo è necessario effettuare il login.
Non sei ancora registrato? Registrati
Bibliografia
1. Pauchard JY, Chehade H, Kies CZ, Girardin
E, Cachat F, Gehri M. Avoidance of voiding
cystourethrography in infants younger
than 3 months with Escherichia coli urinary
tract infection and normal renal ultrasound.
Arch Dis Child 2017;102(9):804-8.
2. Herz AM, Greenhow TL, Alcantara J, et al.
Changing epidemiology of outpatient bacteremia
in 3- to 36-month-old children after
the introduction of the heptavalent conjugated
pneumococcal vaccine. Pediatr Infect Dis
J 2006;25:293-300.
3. Morello W, La Scola C, Alberici I, Montini
G. Acute pyelonephritis in children. Pediatr
Nephrol 2016;31(8):1253-65.
4. Mori R, Lakhanpaul M, Verrier-Jones K.
Diagnosis and management of urinary tract
infection in children: summary of NICE guidance.
BMJ 2007;335:395-7.
5. Subcommittee On Urinary Tract Infection.
Reaffirmation of AAP clinical practice guideline:
the diagnosis and management of the
initial urinary tract infection in febrile infants
and young children 2-24 months of age. Pediatrics
2016;138:138.
6. Montini G, Ammenti A, Cataldi L, et al. Le
infezioni febbrili delle vie urinarie. Raccomandazioni
di consenso per la diagnosi, il
trattamento e il follow-up in bambini di età
compresa fra 2 mesi e 3 anni. Medico e Bambino
2009;28(6):359-70.
7. Ammenti A, Cataldi L, Chimenz R, et al.
Febrile urinary tract infections in young children:
recommendations for the diagnosis,
treatment and follow-up. Acta Paediatr 2012;
101(5):451-7.
8. Honkinen O, Lehtonen OP, Ruuskanen O,
Huovinen P, Mertsola J. Cohort study of bacterial
species causing urinary tract infection
and urinary tract abnormalities in children.
BMJ 1999;318(7186):770-1.
9. Jantunen ME, Siitonen A, Ala-Houhala M,
et al. Predictive factors associated with significant
urinary tract abnormalities in infants
with pyelonephritis. Pediatr Infect Dis J 2001;
20(6):597-60.
10. Friedman S, Reif S, Assia A, Mishaal R,
Levy I. Clinical and laboratory characteristics
of non-E. coli urinary tract infections. Arch
Dis Child 2006;91(10):845-6.
11. Hung TW, Tsai JD, Liao PF, Sheu JN.
Role of renal ultrasonography in predicting
vescicoureteral reflux and renal scarring in
children hospitalized witha first febrile urinary
tract infection. Pediatr Neonatol 2016;57
(2):113-9.
12. Ismaili K, Lolin K, Damry N, et al. Febrile
urinary tract infections in 0- to 3-month-old
infants: a prospective follow-up study. J Pediatr
2011;158(1):91-4.
13. Kaneko K, Kimata T, Kino M. Vesicoureteric
reflux in infants with febrile urinary
tract infection: avoiding a cystourethrogram
cannot be justified yet. J Pediatr 2011;
159(2):352.
14. Toffolo A, Ammenti A, Montini G. Longterm
clinical consequences of urinary tract
infections during childhood: a review. Acta
Paediatr 2012;101(10):1018-31.
15. Peratoner L, Manzoni G. Pielonefrite e reflusso
vescico-ureterale. Medico e Bambino
1999;18(9):550-4.
16. Panaretto K, Craig J, Knight J, et al. Risk
factors for recurrent urinary tract infection in
preschool children. J Paediatr Child Health
1999;35(5):454-9.
17. Keren R, Shaikh N, Pohl H, et al. Risk factors
for recurrent urinary tract infection and
renal scarring. Pediatrics 2015;136(1):e13-21.
18. Tullus K. Vesicoureteric reflux in children.
Lancet 2015;385(9965):371-9.
19. Lazzerini M, Pennesi M, Marchetti F. Il
reflusso vescico ureterale. Medico e Bambino
pagine elettroniche 2005; 8(1).
20. Williams G, Craig JC. Long-term antibiotics
for preventing recurrent urinary tract
infection in children. Cochrane Database
Syst Rev 2011;(3):CD001534.
21. Ingelfinger JR, Stapleton FB. Antibiotic
prophylaxis for vesicoureteral reflux-answers,
yet questions. N Engl J Med 2014;370
(25):2440-1.
22. Wang HH, Gbadegesin RA, Foreman JW, et
al. Efficacy of antibiotic prophylaxis in children
with vesicoureteral reflux: systematic review
and meta-analysis. J Urol 2015;193(3): 963-9.
23. Hewitt IK, Pennesi M, Morello W, Ronfani
L, Montini G. Antibiotic prophylaxis for
urinary tract infection-related renal scarring:
a systematic review. Pediatrics 2017;139(5).
Corrispondenza: federico.marchetti@auslromagna.it